MX2017008748A - Ensayo para detectar dipeptidil peptidasa iv (dpp-4) humana. - Google Patents
Ensayo para detectar dipeptidil peptidasa iv (dpp-4) humana.Info
- Publication number
- MX2017008748A MX2017008748A MX2017008748A MX2017008748A MX2017008748A MX 2017008748 A MX2017008748 A MX 2017008748A MX 2017008748 A MX2017008748 A MX 2017008748A MX 2017008748 A MX2017008748 A MX 2017008748A MX 2017008748 A MX2017008748 A MX 2017008748A
- Authority
- MX
- Mexico
- Prior art keywords
- assay
- dpp
- detect human
- human dpp
- antibodies
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
Abstract
La presente invención se refiere a un ensayo sólido, sensible y específico para la detección y medición de los niveles de DPP-4 en muestras obtenidas de pacientes humanos. La descripción adicionalmente proporciona nuevos anticuerpos monoclonales anti-DPP-4 que reconocen la DPP-4 humana, y kits de ensayo que comprenden uno o más de estos anticuerpos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562101697P | 2015-01-09 | 2015-01-09 | |
PCT/US2016/012603 WO2016112261A2 (en) | 2015-01-09 | 2016-01-08 | Assay to detect human dpp-4 |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2017008748A true MX2017008748A (es) | 2017-11-17 |
Family
ID=56356576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2017008748A MX2017008748A (es) | 2015-01-09 | 2016-01-08 | Ensayo para detectar dipeptidil peptidasa iv (dpp-4) humana. |
Country Status (14)
Country | Link |
---|---|
US (2) | US10351630B2 (es) |
EP (1) | EP3242686B1 (es) |
JP (1) | JP2018502577A (es) |
KR (1) | KR20170098941A (es) |
CN (1) | CN107206079A (es) |
AU (1) | AU2016205188A1 (es) |
BR (1) | BR112017011724A2 (es) |
CA (1) | CA2970540A1 (es) |
HK (2) | HK1243953A1 (es) |
IL (1) | IL252528A0 (es) |
MX (1) | MX2017008748A (es) |
RU (1) | RU2017127182A (es) |
SG (1) | SG11201705598VA (es) |
WO (1) | WO2016112261A2 (es) |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681718A (en) | 1986-03-14 | 1997-10-28 | Celltech Limited | Methods for enhanced production of tissue plasminogen activator in cell culture using alkanoic acids or salts thereof |
US5892019A (en) | 1987-07-15 | 1999-04-06 | The United States Of America, As Represented By The Department Of Health And Human Services | Production of a single-gene-encoded immunoglobulin |
US7115555B2 (en) * | 1998-07-09 | 2006-10-03 | Baylor College Of Medicine | Hypohidrotic ectodermal dysplasia genes and proteins |
US6573096B1 (en) * | 2000-04-01 | 2003-06-03 | The Research Foundation At State University Of New York | Compositions and methods for inhibition of cancer invasion and angiogenesis |
EP1392361A4 (en) * | 2001-05-11 | 2009-08-05 | Univ Texas | THERAPY BASED ON ANTI-CD26 MONOCLONAL ANTIBODIES AGAINST DISORDERS ASSOCIATED WITH CELLS EXPRESSING CD26 |
GB0216648D0 (en) | 2002-07-18 | 2002-08-28 | Lonza Biologics Plc | Method of expressing recombinant protein in CHO cells |
WO2004104216A2 (en) | 2003-05-21 | 2004-12-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) |
GB0407315D0 (en) | 2003-07-15 | 2004-05-05 | Cambridge Antibody Tech | Human antibody molecules |
WO2005075514A2 (en) | 2004-03-10 | 2005-08-18 | Lonza Ltd. | Method for producing antibodies |
WO2007014169A2 (en) * | 2005-07-22 | 2007-02-01 | Y's Therapeutics Co, Ltd. | Anti-cd26 antibodies and methods of use thereof |
WO2008091814A2 (en) | 2007-01-22 | 2008-07-31 | Wyeth | Assessment of asthma and allergen-dependent gene expression |
EP2631302A3 (en) | 2008-03-31 | 2014-01-08 | Genentech, Inc. | Compositions and methods for treating and diagnosing asthma |
US20100221752A2 (en) | 2008-10-06 | 2010-09-02 | Somalogic, Inc. | Ovarian Cancer Biomarkers and Uses Thereof |
US20130310266A1 (en) * | 2010-09-03 | 2013-11-21 | Immport Therapeutics, Inc. | Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders |
WO2012049278A1 (en) | 2010-10-15 | 2012-04-19 | Medimmune Limited | Therapies for improving pulmonary function |
AU2011343570B2 (en) | 2010-12-16 | 2016-11-03 | Genentech, Inc. | Diagnosis and treatments relating to TH2 inhibition |
US8961965B2 (en) | 2011-05-18 | 2015-02-24 | Medimmune, Llc | Methods of diagnosing and treating pulmonary diseases or disorders |
WO2015112970A1 (en) | 2014-01-27 | 2015-07-30 | Medimmune, Llc | Dipeptidyl peptidase-4 (dpp4/cd26) as a peripheral biomarker of il-13 activation in asthmatic lung |
-
2016
- 2016-01-08 BR BR112017011724-0A patent/BR112017011724A2/pt not_active Application Discontinuation
- 2016-01-08 EP EP16735457.0A patent/EP3242686B1/en active Active
- 2016-01-08 JP JP2017536325A patent/JP2018502577A/ja active Pending
- 2016-01-08 SG SG11201705598VA patent/SG11201705598VA/en unknown
- 2016-01-08 AU AU2016205188A patent/AU2016205188A1/en not_active Abandoned
- 2016-01-08 CA CA2970540A patent/CA2970540A1/en not_active Abandoned
- 2016-01-08 CN CN201680005264.3A patent/CN107206079A/zh active Pending
- 2016-01-08 US US14/991,160 patent/US10351630B2/en active Active
- 2016-01-08 MX MX2017008748A patent/MX2017008748A/es unknown
- 2016-01-08 KR KR1020177021858A patent/KR20170098941A/ko unknown
- 2016-01-08 RU RU2017127182A patent/RU2017127182A/ru not_active Application Discontinuation
- 2016-01-08 WO PCT/US2016/012603 patent/WO2016112261A2/en active Application Filing
-
2017
- 2017-05-25 IL IL252528A patent/IL252528A0/en unknown
-
2018
- 2018-03-14 HK HK18103568.6A patent/HK1243953A1/zh unknown
- 2018-03-22 HK HK18103970.8A patent/HK1244444A1/zh unknown
-
2019
- 2019-06-06 US US16/433,174 patent/US20190352425A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2016205188A1 (en) | 2017-06-22 |
EP3242686B1 (en) | 2020-07-08 |
WO2016112261A2 (en) | 2016-07-14 |
CA2970540A1 (en) | 2016-07-14 |
US20190352425A1 (en) | 2019-11-21 |
EP3242686A4 (en) | 2018-06-06 |
EP3242686A2 (en) | 2017-11-15 |
RU2017127182A (ru) | 2019-02-11 |
BR112017011724A2 (pt) | 2018-05-15 |
WO2016112261A3 (en) | 2016-09-01 |
HK1243953A1 (zh) | 2018-07-27 |
CN107206079A (zh) | 2017-09-26 |
US10351630B2 (en) | 2019-07-16 |
US20160200832A1 (en) | 2016-07-14 |
JP2018502577A (ja) | 2018-02-01 |
KR20170098941A (ko) | 2017-08-30 |
IL252528A0 (en) | 2017-07-31 |
HK1244444A1 (zh) | 2018-08-10 |
SG11201705598VA (en) | 2017-08-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020009021A (es) | Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco. | |
PH12019501146A1 (en) | Radiolabeled anti-pd-l1 antibodies for immuno-pet imaging | |
IL289907B (en) | Methods and systems for identification and analysis of tested material | |
BR112016027475A2 (pt) | kit, dispositivo e método para a detecção de câncer pancreático | |
EP3654036A3 (en) | Stomach cancer biomarker and detection method | |
WO2015114506A3 (en) | Biosensors for the detection of infection and associated maladies | |
MX2019007653A (es) | Métodos para la optimización de ensayos rápidos de susceptibilidad antimicrobiana. | |
BR112016028944A2 (pt) | kit ou dispositivo para a detecção de câncer do trato biliar e método de detecção | |
MA40390A (fr) | Procédés d'analyse impliquant des nanoparticules dissociables | |
MX2016013255A (es) | Metodos y composiciones para detectar proteinas mal plegadas. | |
PH12019501837A1 (en) | Radiolabeled anti-lag3 antibodies for immuno-pet imaging | |
IL254687A0 (en) | A bio-sensor system for rapid identification of an analyte | |
PH12017500765A1 (en) | Malaria detection | |
MX2016009490A (es) | Ensayo novedoso para detectar periostina humana. | |
EP3299816A4 (en) | Separation method, detection method, signal measurement method, disease determination method, drug efficacy assessment method, kit, liquid composition, and specimen diluent | |
MX2017007232A (es) | Ensayos de desplazamiento por movilidad homogeneos indirectos para la deteccion de productos biologicos en muestras de pacientes. | |
MA40636A (fr) | Procédés pour détecter le cancer de la prostate | |
MX2018002467A (es) | Anticuerpos y ensayos para deteccion del antigeno leucocitico (cd37). | |
MX2016010499A (es) | Sistemas y métodos para identificar subtipos del receptor de progesterona. | |
MX2019011702A (es) | Ensayos de inmunogenicidad mejorados. | |
MY192159A (en) | Method for detecting neutralizing antibodies against recombinant human insulin in human serum | |
EP3721229A4 (en) | LATERAL FLOW ASSAY AND METHOD OF DETECTING HIGH CONCENTRATION ANALYTES | |
MX2017008748A (es) | Ensayo para detectar dipeptidil peptidasa iv (dpp-4) humana. | |
MY187731A (en) | In vivo induced toxoplasma gondii protein for application in diagnosis, vaccine and therapy | |
SG10201901836PA (en) | Test strip assembly |